Hosted on MSN11h
Leerink Partners Upgrades Regeneron Pharmaceuticals (REGN)
Fintel reports that on February 5, 2025, Leerink Partners upgraded their outlook for Regeneron Pharmaceuticals (NasdaqGS:REGN) from Market Perform to Outperform. Analyst Price Forecast Suggests 42.56% ...
Metro Nashville high school student selected as finalist in national science competition
A Metro Nashville Public Schools student was recently selected as one of 40 finalists in the Regeneron Science Talent Search.